Advertisement
Microsphere particles, including Boston Scientific's Contour SE, BiosphereMedical's Embosphere, and others, were used in 40% of these treatments.Overall, chemoembolization particles generated nearly 20% of total microsphererevenue. As such, chemoembolization procedures are a key segment in theoverall embolic particle market, which, in addition to standard microspheres,includes drug-infused microspheres, selective internal radiation therapy(SIRT) spheres, and polyvinyl alcohol (PVA) particles. MRG's US IRMarketrack(TM) service monitors the adoption of embolic particles for livercancer, uterine fibroids, aneurysms, hemorrhages, and vascular anomalies.
Advertisement
"In chemoembolization, chemotherapy agents are mixed with embolicparticles and are delivered through a catheter directly to the tumor, therebylocalizing the chemo treatment" says Phil Scrutton, Analyst at MRG. "Theparticles also embolize the surrounding arteries, blocking blood flow to thecancerous tissue. This slows diffusion of the chemotherapy agents away fromthe tumor, which increases its effectiveness in targeting the liver tumor,while the embolization also deprives the tumor of oxygen and nutrients."
Liver cancer has historically had a poor prognosis, but the use of embolicparticles in conjunction with drugs in chemoembolization, while not a cure, isleading to longer life expectancies for cancer sufferers. These positiveclinical outcomes, the availability of improved embolization technologies, andan increasing rate of patient referrals for this treatment are allcontributing to embolic particle market growth.
Millennium Research Group will be attending the Society of InterventionalRadiology annual meeting in Washington, DC from March 16-19. Come to booth#304 to discover how we can help you meet your needs.
About Interventional Radiology Marketrack(TM)
IR Marketrack(TM) gathers quarterly data from interventional radiologylabs throughout the US, including data on PV embolizations, varicose veintreatments, and vascular access procedures. Marketrack(TM) subscribersreceive thousands of data points, including usage (units, average sellingprice, and revenue), procedure, competitor, and device brand information.
About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc.company (www.DecisionResources.com), is the global authority on medicaltechnology market intelligence and a leading provider of strategic informationto the health care sector. Focused solely on the medical device,pharmaceutical, and biotechnology industries, the company provides its clientswith the benefits of its specialized industry expertise through publishedreports and customized consulting services.
All company, brand, or product names contained in this document may betrademarks or registered trademarks of their respective holders.For more information, contact: Amy Krohn Millennium Research Group 416-364-7776 x101 [email protected]
SOURCE Millennium Research Group
